Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2000009	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2020-08-21		Medimmune LLC;Catalent Indiana LLC	In Review	2020-08-19	view
JXSB2000012	度伐利尤单抗注射液	durvalumab	Injection	Biological Products(2.2)	Supplementary Application	2020-09-10		Medimmune LLC;Catalent Indiana LLC	In Review	2020-09-09	view
JXSB2000022	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2020-09-29		Medimmune LLC;Catalent Indiana LLC	In Review	2020-09-28	view
JXSB2000041	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2020-12-03		Medimmune LLC;Catalent Indiana LLC	In Review	2020-12-03	view
JXSB2000050	Durvalumab	durvalumab	Injection	Biological Products(2.2)	Supplementary Application	2020-12-21		Medimmune LLC;Catalent Indiana LLC	In Review	2021-05-09	view
JXSB2100004	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2021-01-08		Medimmune LLC;Catalent Indiana LLC	In Review	2021-01-07	view
JXSB2100011	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2021-02-06		Medimmune LLC;Catalent Indiana LLC	In Review	2021-02-05	view
JXSB2101019	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2021-06-11		Medimmune LLC;Catalent Indiana LLC			view
JXSB2101027	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2021-06-21		Medimmune LLC;Catalent Indiana LLC			view
JXSB2101044	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2021-08-09		Medimmune LLC;Catalent Indiana LLC			view
JXSB2101064	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2021-10-12		Medimmune LLC;Catalent Indiana LLC			view
JXSB2200046	度伐利尤单抗注射液	durvalumab	Injection	Biological Products	Supplementary Application	2022-04-24		Medimmune LLC;Catalent Indiana LLC			view
JXSB2200123	Durvalumab	durvalumab	Injection	Biological Products	Supplementary Application	2022-09-27		Medimmune LLC;Catalent Indiana LLC			view
JXSL1500002	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-02-11	阿斯利康投资(中国)有限公司	Astrazeneca Investment (China) Co Ltd;Medimmune LLC	Certificate Issued	2016-08-25	view
JXSL1500041	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-08-12	阿斯利康投资(中国)有限公司	Astrazeneca Investment (China) Co Ltd;Medimmune LLC	Certificate Issued	2016-08-25	view
JXSL1500045	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-08-12	丘以思（上海）医药信息咨询有限公司	Choice Pharma Medical Information Consultancy (Shanghai) Co Ltd;Medimmune LLC	Certificate Issued	2016-08-08	view
JXSL1500062	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-11-26	MedImmune LLC	Medimmune LLC	Certificate Issued	2017-01-03	view
JXSL1500064	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-11-26	MedImmune LLC	Medimmune LLC	Certificate Issued	2016-08-25	view
JXSL1500066	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-11-26	MedImmune LLC	Medimmune LLC	Certificate Issued	2016-09-29	view
JXSL1500072	MEDI4736	durvalumab	Injection	Biological Products	Import Drug Application	2015-12-11	MedImmune LLC	Medimmune LLC	Certificate Issued	2016-11-08	view